Streamlining Care for Patients With Compression Neuropathies: The Carpal Tunnel Plus Pathway

The goal of this clinical trial is to assess the impact of a new care pathway (the Carpal Tunnel Plus Pathway) in patients with carpal tunnel syndrome. The main questions it aims to answer are:

1. What was the effect of the Carpal Tunnel Plus Pathway on wait times between each step of the care pathway (e.g. from referral to initial consult, from initial consult to surgical consult, etc.)? 2. How satisfied are patients with the care they received through the Carpal Tunnel Plus Pathway?

Researchers will compare wait times pre- and post- Pathway implementation to see if there was any change.

Participants will be asked to complete a short patient satisfaction survey.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Carpal Tunnel Syndrome (CTS) Behavior Carpal Tunnel Syndrome Cumulative Trauma Disorders Health Behavior Median Neuropathy Mononeuropathies Nerve Compression Syndromes Nervous System Diseases Neuromuscular Diseases Patient Satisfaction Peripheral Nervous System Diseases Sprains and Strains Treatment Adherence and Compliance Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Vancouver General Hospital

Vancouver, British Columbia, V5Z 1M9, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years of age or older
Referred to the Vancouver General Hospital Neuromuscular Disease Unit or St. Paul's Hospital with a confirmed diagnosis of carpal tunnel syndrome
Ability to understand English

Exclusion criteria

Inability to provide informed consent

Treatment and study plan

Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway)

Procedure

Changes to the care pathway for carpal tunnel syndrome. Features of the CTS+ pathway include new referral form, care map for mild, moderate and severe CTS established, point or care ultrasound with steroid injection introduced, and expedited referral to surgeons.

Primary outcomes

Wait times

Time frame: From initial referral to surgery/injection (variable, but approximately 9 months)

Time between each step of the care pathway (e.g. from referral to EMG/neurologic consultation, from referral to surgical consultation, from surgical consultation to surgery)
Patient satisfaction

Time frame: Immediately after surgery/injection appointment

Patients will be asked to complete a short questionnaire to indicate their level of satisfaction with the care that they received. The custom survey will consist of 4 questions on various aspects of their care that participants will rate on a scale of 1-5 (1 = not at all satisfied, 5 = very satisfied).

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Registry information

Acronym: CTS+ Pathway

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Dec 5, 2024
Registry last updated: Dec 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Enrolling by Invitation